Socioeconomic status and quality of life in patients with locally advanced head and neck cancer

被引:0
|
作者
Tribius, S. [1 ]
Meyer, M. S. [2 ]
Pflug, C. [3 ]
Hanken, H. [4 ]
Busch, C. -J. [5 ]
Kruell, A. [2 ]
Petersen, C. [2 ]
Bergelt, C. [6 ]
机构
[1] Asklepios Hosp St Georg, Dept Radiat Oncol, Lohmuhlenstr 5, D-20099 Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Dept Radiat Oncol, Hamburg, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Dept Voice Speech & Hearing Disorders, Ctr Clin Neurosci, Hamburg, Germany
[4] Univ Med Ctr Hamburg Eppendorf, Dept Oral & Maxillofacial Surg, Ctr Clin Neurosci, Hamburg, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Dept Otolaryngol, Ctr Clin Neurosci, Hamburg, Germany
[6] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany
关键词
Quality of life; Head and neck cancer; Intensity-modulated radiotherapy; Rehabilitation; Socioeconomic status; HUMAN-PAPILLOMAVIRUS; EORTC QLQ-C30; SURVIVAL; QUESTIONNAIRE; QLQ-H-AND-N35; RADIOTHERAPY; PREVALENCE; VALIDATION; ONTARIO; CANADA;
D O I
10.1007/s00066-018-1305-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Socioeconomic aspects play an important role in health care. Patients with locally advanced head and neck cancer (LAHNC) experience detrimental effects on their quality of life (QoL). This prospective study examines QoL differences between patients with different socioeconomic status (SES) after intensity-modulated radiation therapy (IMRT). In all, 161 patients were questioned at the end of IMRT and at 12 and 24 months follow-up using the questionnaires of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-30 and QLQ-HN35. Patients' QoL 2 years after IMRT was compared to a population reference sample and QoL of patients from lower, middle, and higher social class 2 years after IMRT was analyzed by ANCOVA using baseline QoL (end of radiation treatment) as a covariate. Patients with high SES report worse QoL at the end of IMRT in the domains global health status (-15.2; p= 0.005), role function (-23.8; p= 0.002), and social function (-19.4; pN= 0.023) compared to patients with middle and low SES. QoL improved during the first 12 and 24 months. However, 2 years after IMRT, middle and low SES patients report lower QoL in the domains global health status, physical function, and role function, and report a higher general (fatigue, pain, dyspnea) and head and neck cancer-specific symptom burden (pain, swallowing, senses, speech, social eating, opening mouth, and felt ill) than patients with high SES. After IMRT for LAHNC, patients with high SES report worse QoL compared to patients with middle or low SES. There is a marked improvement within the first 24 months in many domains. However, the magnitude of improvement in patients with middle or low SES is significantly smaller compared to patients with high SES.
引用
收藏
页码:737 / 749
页数:13
相关论文
共 50 条
  • [1] Quality of life in patients with locally advanced head and neck cancer with concomitant chemoradiotherapy
    Angel, S.
    Laura, P.
    Jorge, M.
    Jose, P.
    Alejandra, G.
    Roberto, D.
    Miguel, P.
    Joaquin, M.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 374 - 374
  • [2] Quality of Life and Psychological Distress in Patients With Locally Advanced Head and Neck Cancer
    Bellver-Perez, Ascension
    Segura Huerta, Angel
    [J]. PSYCHO-ONCOLOGY, 2014, 23 : 400 - 401
  • [3] Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment
    Giorgio Capuano
    Pier Carlo Gentile
    Federico Bianciardi
    Michela Tosti
    Anna Palladino
    Mario Di Palma
    [J]. Supportive Care in Cancer, 2010, 18 : 433 - 437
  • [4] Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment
    Capuano, Giorgio
    Gentile, Pier Carlo
    Bianciardi, Federico
    Tosti, Michela
    Palladino, Anna
    Di Palma, Mario
    [J]. SUPPORTIVE CARE IN CANCER, 2010, 18 (04) : 433 - 437
  • [5] Assessment of quality of life in patients with locally advanced head and neck cancer who received concurrent chemoradiotherapy
    Abd Allah, Hatem
    Zaied, Marwa
    Soliman, Doaa
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [6] The Impact of Prophylactic Percutaneus Endoscopic Gastrostomy to Nutritional Status and Quality of Life in Locally Advanced Head and Neck Cancer Patients Receiving Chemoradiotherapy
    Yonal, Oya
    Atasoy, Beste M.
    Demirel, Birsen
    Yilmaz, Yusuf
    Dane, Faysal
    Abacioglu, Ufuk
    Kalayci, Cem
    Imeryuz, Nese
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S235 - S235
  • [7] Quality of life following chemoradiation and postoperative radiation for locally advanced head and neck cancer
    Nguyen, Nam P.
    Vos, Paul
    Karlsson, Ulf
    Nguyen, Phuc
    Dutta, Suresh
    Lemanski, Claire
    Ludin, Adir
    Rose, Sue
    Nguyen, Ly M.
    Ward, Harold
    Huang, Shawn
    Sallah, Sabah
    [J]. ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 2007, 69 (05): : 271 - 276
  • [8] Quality-of-Life Evaluation of Patients with Unresectable Locally Advanced or Locally Recurrent Head and Neck Carcinoma Treated with Head and Neck Photoimmunotherapy
    Okamoto, Isaku
    Okada, Takuro
    Tokashiki, Kunihiko
    Tsukahara, Kiyoaki
    [J]. CANCERS, 2022, 14 (18)
  • [9] EGFR Status and Prognosis of Patients with Locally Advanced Head and Neck Cancer Treated with Chemoradiotherapy
    Numico, Gianmauro
    Russi, Elvio Grazioso
    Colantonio, Ida
    Lantermo, Rosa Anna
    Silvestris, Nicola
    Vitiello, Raffaele
    Comino, Alberto
    Abrate, Mario
    Zavattero, Carla
    Melano, Antonella
    Merlano, Marco
    [J]. ANTICANCER RESEARCH, 2010, 30 (02) : 671 - 676
  • [10] Socioeconomic status and quality of life in patients with locally advanced head and neck cancer; [Sozioökonomischer Status und Lebensqualität bei Patienten mit lokal fortgeschrittenen Kopf-Hals-Tumoren]
    Tribius S.
    Meyer M.S.
    Pflug C.
    Hanken H.
    Busch C.-J.
    Krüll A.
    Petersen C.
    Bergelt C.
    [J]. Strahlentherapie und Onkologie, 2018, 194 (8) : 737 - 749